Contact Us

Free ParentSmart Healthline^TM

Caring pediatric nurses are available 24/7 to help answer your health questions.

720-777-0123

Send Postal Mail To:

Children’s Hospital Colorado
Anschutz Medical Campus
13123 East 16th Avenue
Aurora, CO 80045

Looking for a different location?

Locations

Emergency Locations

Urgent Care Locations

Locations Near You

See All Locations

Paul Wadwa, MD

Director of Telemedicine, Barbara Davis Center
Medical Director, Pediatric Clinic, Barbara Davis Center
Associate Professor of Pediatrics

Specialties:: Endocrinology - Pediatric, Pediatrics
Conditions:: Juvenile Diabetes

303-724-2323

Get to know his background

Clinical interests

Type 1 Diabetes, Clinical trials in type 1 diabetes, Telemedicine, artificial pancreas technology

Undergraduate 1992

Northwestern University (IL)

Medical School 1996

Northwestern University The Feinberg School of Medicine

Internship 1997

Nationwide Children's Hospital/Ohio State University Program

Residency 2000

Nationwide Children's Hospital/Ohio State University Program, Pediatrics

Fellowship 2003

Cincinnati Children's Hospital Medical Center Program, Pediatric Endocrinology

O'Brien Fellowship Award 2015

Children's Diabetes Foundation/ Barbara Davis Center

For Patients:
My primary research focus is on the development of the artificial pancreas for patients with type 1 diabetes. I am involved in many clinical research studies with the goal of advancing artificial pancreas technology. I am also engaged in clinical trials of new therapeutic agents as well as research describing the effects of a clinical telemedicine program on diabetes control for youth with type 1 diabetes. My hope is that the research I am involved with will greatly improve the tools available to optimize control and reduce the burden of diabetes for patients locally and beyond.

For Referring Providers:
Dr. Wadwa’s research primarily focuses on the development of the artificial pancreas. He is engaged as a site PI and as a co-investigator for several NIH-sponsored and industry- sponsored clinical research studies with the goal of advancing artificial pancreas technology. Dr. Wadwa is also engaged in clinical trials of new therapeutic agents as well as research describing the effects of a clinical telemedicine program on glycemic control in pediatric type 1 diabetes patients.